Skip to main content
Home
News
Live
Companies
Pricing
About Us
Language
...
Sign In
Register
#FDA News | Tervion
Back to News
Tag: #FDA
6 articles
Title
Company
Published
FDA extends review of weekly LEQEMBI IQLIK for initial Alzheimer's use to Aug. 24, 2026
#FDA
#Alzheimer's disease
#LEQEMBI IQLIK
#Biogen
#Eisai
Tervion
May 9, 2026
FDA’s April neurology actions: Auvelity approval, CRL for IV nimodipine, tremor device clearance, gene therapy date set
#FDA
#neurology
#drug approvals
#gene therapy
#medical devices
Tervion
May 9, 2026
FDA Fast-Track Sets Stage for Possible First Psychedelic Approvals by Fall
#FDA
#psychedelic therapies
#depression treatment
#PTSD
Tervion
May 4, 2026
FDA issues priority vouchers for psychedelics, approves hearing-loss gene therapy under voucher pilot
#FDA
#drug regulation
#psychedelics research
#gene therapy
#animal testing alternatives
Tervion
Apr 25, 2026
FDA to offer ultra-fast review for three psychedelic therapies after Trump order
#FDA
#psychedelics
#psilocybin
#PTSD treatment
#executive order
Tervion
Apr 24, 2026
FDA tightens medical device cybersecurity guidance, setting tougher lifecycle requirements
#FDA
#medical devices
#cybersecurity
#healthcare IT
#Health-ISAC
Tervion
Apr 15, 2026
